Treatments Do Not Increase Infection Risk in Ankylosing Spondylitis
A large Canadian study of the drug use in ankylosing spondylitis (AS) demonstrated no evidence that the risk of serious, hospitalized infection was influenced by the use of DMARD and/or of tumour necrosis factor inhibitors (TNFi) therapy.


